Physician profile
Edgar Camargo
NPI 1235112558
$2,713.82
in general payments reported to CMS, 2019-2025
18 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,191 · 2020: $130 · 2022: $148 · 2023: $159 · 2024: $795 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $680.37 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $473.63 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $418.74 | 2019-2024 | Spravato |
| Amgen INC. | $219.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.96 | 2019 | |
| Dexcom, INC. | $125.00 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.83 | 2024 | Xifaxan |
| Novo Nordisk INC | $99.00 | 2019 | |
| Lilly USA, LLC | $90.71 | 2019 | |
| Exact Sciences Corporation | $72.08 | 2024-2025 | Cologuard Collection Kit |
| Allergan, INC. | $66.41 | 2019 | |
| Abbvie INC. | $34.17 | 2023 | Mavyret |
| Circassia INC. | $26.29 | 2019 | |
| Pfizer INC. | $24.51 | 2019 | |
| Merck Sharp & Dohme LLC | $23.41 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.32 | 2022 | |
| Mylan Specialty L.P. | $15.38 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Camargo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.